PALISADE BIO, INC. — Director's Dealing 2013

Jan 30, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2012-12-31

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-11	Common Stock Purchase Option	$1.09	A	738479	Acquired	2022-04-11	Common Stock (738479)	Direct

Footnotes

F1: Right to Buy

F2: Represents Reporting Person's long-term incentive grant for 2012, which was granted on April 11, 2012. The option was granted pursuant to the company's 2010 Equity Compensation Plan.

F3: For so long as Reporting Person continues to be a service provider, the Option vests quarterly over a three year period commencing on the April 11, 2012, the Grant Date.